Seroquel XR in schizophrenia relapse prevention
Study identifier:NIS-NHU-SER-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Seroquel XR in schizophrenia relapse prevention
Medical condition
schizophrenia relapse prevention
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1600
Study type
Observational
Age
18 Years - 70 Years
Date
Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Schizophrenic outpatients | - |
Contacts
Investigators
Principal Investigator
Attila Németh
National Psychiatric Centre
